Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

A new study suggests that dementia may be driven in part by faulty blood flow in the brain. Researchers found that losing a ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...

Dr. Mark Houston, MD, FACP, a cardiologist and the director of the Hypertension Institute, reiterates that water is important ...

An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...

Let’s clear up any confusion right now: Green tea is a great drink for heart health, including for people with hypertension.

First Study to Use a pTau217 Blood Test to Detect Alzheimer's Disease Early and at Scale CARLSBAD, Calif., Dec. 17, 2025 /PRNewswire/ -- ALZpath, Inc., a leading developer of innovative diagnostic ...

People who had achieved prediabetes remission had a 58 percent lower risk of cardiovascular death or hospitalization from ...

Patients with depression are at higher risk of cardiovascular disease, and a new study suggests that stress may help explain ...

Chronic kidney disease (CKD) significantly amplifies cardiovascular (CV) risk, with CV disease remaining the leading cause of ...